Only accredited investors can buy flow-through shares from companies directly, though non-accredited investors can access them through limited partnerships where money is pooled and allocated into a ...

After-Tax NPV (5%) of $425 Million with an After-Tax IRR of 30.9% at US$2,500 / oz Gold After-Tax NPV (5%) of $793 Million with an After-Tax IRR of 47.3% at Spot Gold (US$3,300 / oz) Canagold ...

How we picked the best-performing AI stocks Defining AI as the study and development of machine-based systems capable of learning from experience, we put together a list of 10 high-performing stocks ...

Discover the top Canadian lithium stocks, companies, their market performance, and future growth potential in this booming sector for 2024 ...

Welcome to the Capital Compass, I’m Lyndsay Malchuk. 3D content isn’t just the future, it’s the now. And Nextech3D.ai (CSE:NTAR, OTCQB:NEXCF) just lit a fire under that reality. The company has inked ...

MediPharm Labs (TSX:LABS) has begun production for its novel cannabis metered dose inhalers (MDIs) tailored for the EU and UK markets.

Tungsten, a metal critical to national security, is under more than 80 per cent Chinese control, incentivizing new Western supply.

EDMONTON, AB, Sept. 15, 2025 /CNW/ - K-Bro Linen Inc. (the "Corporation") announced today a dividend of 10.00 cents CDN per common share of the Corporation for the period from September 1 to 30, 2025, ...

(1) Reflects aggregate amounts for the most recent four quarters, as detailed in the table in the Quarterly Consolidated Financial Information section of the First Quarter 2025 Report to Shareholders.

Canadian based Volatus Aerospace Inc. is a leading provider of integrated drone solutions across North America with expanding operations in Latin America and globally. The company serves civil, public ...

(1) Underground mineral resources are reported at a base case cut-off grade of 1.00% CuEq. Values in this table reported above and below the base case cut-off grades should not be misconstrued with a ...

As has been discussed in my previous Stockhouse articles about NervGen, there have been various second-hand reports in online chatrooms which claim that patients in NervGen’s Phase ...